Navigation Links
Med Data Quest Tackles Oncology Informatics Challenges with WuXi AppTec

SAN DIEGO, Nov. 18, 2015 /PRNewswire/ -- Med Data Quest (MDQ), a pioneering medical informatics total solution provider, today celebrates its successful collaboration with the Oncology Business Unit of the CRO giant WuXi AppTec, delivering the world's first mobile App OncoWuXi that was launched in October for customers to access WuXi oncology tumor models and capabilities more quickly and easily for cancer drug discovery and translational research. This marks MDQ's effective expansion of its business scope into pharmaco-geonomics and cancer research field, leveraging data-mining, statistical computing and information technologies.

The San Diego-based start-up company enters the medical informatics industry with a mission to realize personalized medicine with interdisciplinary methods. MDQ first improves disease diagnosis process and accuracy through collaboration with a major healthcare organization in Southern California, and developed machine learning and natural language processing tools to improve the quality of health care and clinical decision-making. Its recently established partnership with WuXi centers on facilitating the development of cancer treatment drugs by combining comprehensive oncology and omics data. The information service is designed to rapidly curate, process and translate raw pharmaco-geonomics data into actionable information, and the frontend webpage and Apps (iOS and Android) provide domain experts with smooth UI, interactive visualizations, and ease of data access to facilitate data interpretation and knowledge extraction.

"The collaboration with MDQ is highly effective and professional," said Qun-Sheng Ji, Vice President and Head of Oncology Business Unit at WuXi AppTec. "The portable and interactive data platform incorporates encompassing information of more than 1,000 cancer patient-derived xenograft (PDX), human cancer cell-derived xenograft (CDX), and syngeneic mouse tumor models. The massive and complicated raw data is swiftly transformed into easy-to-interpret representations accessible from webpage and Apps, thus helps WuXi to offer the users an open, one-stop, and integrated total solution while facilitating cancer research and drug development."

"We are excited to be part of WuXi's global network and take a small step forward towards precision medicine," said Dr. Yuan Gao, President and CEO of MDQ and former Professor at Johns Hopkins University."Through collaborations with industry leaders, MDQ has established itself as a trustworthy partner with interdisciplinary domain knowledge and innovative solutions. With the industry-acclaimed experience and proven results in both clinical medical treatment and pharmaco-genomics field, MDQ is confident to soon develop other cutting-edge services that will advance personalized medicine."

The OncoWuXi App is available in the Apple App store:
Google play store:
and Android direct download:

About Med Data Quest

Med Data Quest (MDQ) is a Medical Informatics / Bioinformatics / Machine Learning service company aimed at transforming medicine and healthcare. With profound experience and interdisciplinary expertise, MDQ has successfully delivered comprehensive solutions to address challenges in the health arena. MDQ is currently hiring and actively seeking partnership in the pharmaceutical, medical and genomics industries.

For more information, please visit

SOURCE Med Data Quest Inc.
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. Cephasonics Unveils Next-Generation Wireless-Imaging Technology for cQuest Ultrasound Hardware Platforms
2. Quest Diagnostics CEO Steve Rusckowski Reaffirms Full-Year 2013 Guidance At The Jefferies 2013 Global Healthcare Conference
3. Quest Diagnostics and Hologic Form Strategic Alliance to Improve Womens Health
4. China Botanic Pharmaceutical Inc. Announces Withdrawal Of Request For Hearing
5. Questcor Adds Angus C. Russell to Board of Directors
6. HemaQuest Pharmaceuticals Completes Patient Enrollment in Phase 2b Clinical Study of HQK-1001 in Patients with Sickle Cell Disease
7. Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company Statement on the ADA Request for Independent Review of Incretin-Based Therapies
8. Ongoing Clinical Trials Reveal Groundbreaking Results - Research Report on Alexion, BioMarin, Onyx, Questcor, and ImmunoGen
9. 227 Congressmen Ask Medicare to Delay Implementing Questionable Procurement Program
10. Pancreatic Cancer Advocates Call on Congress to Protect Medical Research Funding From Sequestration Cuts
11. Mandated Flu Vaccine for Hospital Workers Ethically Questionable, Surgeon Writes
Post Your Comments:
(Date:1/8/2020)... ... January 09, 2020 , ... R3 Stem Cell, the ... freezer program. The cryogenic freezer allows practices to have plenty of stem cell ... exosome biologics require cryogenic freezing. This may include a practice receiving the biologics ...
(Date:1/7/2020)... ... January 07, 2020 , ... Ironsphere, ... service providers, announced today it has been selected by MetLife Stadium for Privileged ... , “As part of our ongoing commitment to maintain the highest of security ...
(Date:1/7/2020)... TORONTO (PRWEB) , ... January 06, 2020 , ... Myant ... that enable continuous and ambient heart health management at CES 2020 (January 7-10, Las ... as a winner in the Health & Wellness category of the CES 2020 Innovation ...
Breaking Medicine Technology:
(Date:1/23/2020)... ... January 23, 2020 , ... DelawareBio, a nonprofit trade ... a panel discussion on gene editing that goes beyond CRISPR technology. To be ... Education Center, the event will provide an overview of the opportunities and challenges ...
(Date:1/23/2020)... ... January 23, 2020 , ... Three leading healthcare organizations, ... to improve diagnostic quality and safety by joining the Coalition to Improve ... healthcare and patient advocacy. , “Diagnostic error is one of the most important ...
(Date:1/23/2020)... (PRWEB) , ... January 23, 2020 , ... ... and risk services for organizations that operate vehicle fleets in North America and ... subscriber-based e-newsletter, will be published monthly with content accessible on the company’s website. ...
(Date:1/23/2020)... Texas (PRWEB) , ... January 23, 2020 , ... ... announced a strategic partnership using SocialClimb’s innovative technology to power the Arrowlytics platform ... practice efficiency and profitability. SocialClimb’s platform integrates seamlessly with practice management systems to ...
(Date:1/22/2020)... (PRWEB) , ... January 22, ... ... cloud-based ambulatory EHR , revenue cycle management services, integrated practice management, ... System, Hospital Information Management System and Personal Health Record for Indian healthcare ...
Breaking Medicine News(10 mins):